https://www.digitalfashionsociety.org/index.php/conference/issue/feed 2026-08-03T16:30:53+03:00 Open Journal Systems https://www.digitalfashionsociety.org/index.php/conference/article/view/322 2026-08-03T16:30:53+03:00 M.G. Lipartia shahram01@inbox.ru M.Sh. Fazliyev shahram01@inbox.ru

<p><span class="fontstyle0">Chemotherapy-induced leukopenia remains one of the principal hematological<br>toxicities limiting systemic anticancer treatment. Although routine monitoring relies on<br>peripheral blood counts, these measurements describe the consequence of bone marrow<br>suppression rather than its underlying biological state. Bone marrow examination provides<br>direct information on hematopoietic activity, granulocytic maturation, and marrow reserve,<br>offering insights that cannot be obtained from peripheral blood analysis alone. Recent<br>studies suggest that combining peripheral blood findings with myelographic characteristics<br>may improve risk assessment and facilitate more individualized supportive care. This<br>review summarizes current evidence on the complementary role of peripheral blood and<br>bone marrow evaluation in predicting chemotherapy-induced leukopenia and discusses<br>their potential clinical application.</span> </p>

2026-08-03T00:00:00+03:00 Copyright (c) 2026 Multidiscipline proceedings of digital fashion conference